A prostacyclin analog beraprost sodium attenuates radiocontrast media-induced LLC-PK1 cells injury

Takahisa Yano, Yoshinori Itoh, Toshio Kubota, Toshiaki Sendo, Ryozo Oishi

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background. We previously reported that the apoptotic injury in a porcine renal tubular cell line LLC-PK1 cells induced by radiographic contrast media is attenuated by dibutyl cyclic adenosine monophosphate (cAMP) in a manner dependent on protein kinase A (PKA). The present study was designed to determine whether the elevation of endogenous cAMP with beraprost sodium, a prostacyclin analog, reduces the contrast material-induced renal tubular injury. Methods. The cell injury was induced by the exposure to ioversol for 30 minutes followed by further incubation for 24 hours in the absence of the contrast medium, and assessed by propidium iodide uptake and WST-8 assay. Apoptosis was determined by annexin V stain and DNA electrophoresis. Caspase activity was assessed by the enzymatic degradation of specific substrate peptides. Bax and bcl-2 mRNA expression were determined by reverse transcription-polymerase chain reaction (RT-PCR). The phosphorylation of cAMP-responsive element binding protein (CREB) was measured by an immunofluorescent method. Results. Beraprost sodium (10 to 1000 nmol/L) attenuated concentration dependently the ioversol-induced decrease in cell viability, in which the protective effect of beraprost sodium was dependent on the elevation of cellular cAMP content. The phosphorylation of CREB was enhanced by beraprost sodium in PKA-dependent manner. In addition, beraprost sodium reversed the ioversol-induced increase in bax mRNA with a concomitant decrease in bcl-2 mRNA and subsequent activation of caspase-3 and -9, thereby resulting in the inhibition of the nuclear damage. Conclusion. Beraprost sodium reversed the contrast media-induced renal tubular cells in culture by activating cAMP/protein kinase A-dependent phosphorylation of CREB and subsequent enhancement of bcl-2 expression.

Original languageEnglish
Pages (from-to)1654-1663
Number of pages10
JournalKidney International
Volume65
Issue number5
DOIs
Publication statusPublished - May 2004

Fingerprint

beraprost
LLC-PK1 Cells
ioversol
Epoprostenol
Contrast Media
Cyclic AMP
Wounds and Injuries
Cyclic AMP-Dependent Protein Kinases
Carrier Proteins
Phosphorylation
Kidney
Messenger RNA
Caspase 9
Propidium
Annexin A5
Caspases
Caspase 3
Reverse Transcription
Electrophoresis
Cell Survival

All Science Journal Classification (ASJC) codes

  • Nephrology

Cite this

A prostacyclin analog beraprost sodium attenuates radiocontrast media-induced LLC-PK1 cells injury. / Yano, Takahisa; Itoh, Yoshinori; Kubota, Toshio; Sendo, Toshiaki; Oishi, Ryozo.

In: Kidney International, Vol. 65, No. 5, 05.2004, p. 1654-1663.

Research output: Contribution to journalArticle

Yano, Takahisa ; Itoh, Yoshinori ; Kubota, Toshio ; Sendo, Toshiaki ; Oishi, Ryozo. / A prostacyclin analog beraprost sodium attenuates radiocontrast media-induced LLC-PK1 cells injury. In: Kidney International. 2004 ; Vol. 65, No. 5. pp. 1654-1663.
@article{0dfbb28dea884fe388892787cb233cf7,
title = "A prostacyclin analog beraprost sodium attenuates radiocontrast media-induced LLC-PK1 cells injury",
abstract = "Background. We previously reported that the apoptotic injury in a porcine renal tubular cell line LLC-PK1 cells induced by radiographic contrast media is attenuated by dibutyl cyclic adenosine monophosphate (cAMP) in a manner dependent on protein kinase A (PKA). The present study was designed to determine whether the elevation of endogenous cAMP with beraprost sodium, a prostacyclin analog, reduces the contrast material-induced renal tubular injury. Methods. The cell injury was induced by the exposure to ioversol for 30 minutes followed by further incubation for 24 hours in the absence of the contrast medium, and assessed by propidium iodide uptake and WST-8 assay. Apoptosis was determined by annexin V stain and DNA electrophoresis. Caspase activity was assessed by the enzymatic degradation of specific substrate peptides. Bax and bcl-2 mRNA expression were determined by reverse transcription-polymerase chain reaction (RT-PCR). The phosphorylation of cAMP-responsive element binding protein (CREB) was measured by an immunofluorescent method. Results. Beraprost sodium (10 to 1000 nmol/L) attenuated concentration dependently the ioversol-induced decrease in cell viability, in which the protective effect of beraprost sodium was dependent on the elevation of cellular cAMP content. The phosphorylation of CREB was enhanced by beraprost sodium in PKA-dependent manner. In addition, beraprost sodium reversed the ioversol-induced increase in bax mRNA with a concomitant decrease in bcl-2 mRNA and subsequent activation of caspase-3 and -9, thereby resulting in the inhibition of the nuclear damage. Conclusion. Beraprost sodium reversed the contrast media-induced renal tubular cells in culture by activating cAMP/protein kinase A-dependent phosphorylation of CREB and subsequent enhancement of bcl-2 expression.",
author = "Takahisa Yano and Yoshinori Itoh and Toshio Kubota and Toshiaki Sendo and Ryozo Oishi",
year = "2004",
month = "5",
doi = "10.1111/j.1523-1755.2004.00575.x",
language = "English",
volume = "65",
pages = "1654--1663",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - A prostacyclin analog beraprost sodium attenuates radiocontrast media-induced LLC-PK1 cells injury

AU - Yano, Takahisa

AU - Itoh, Yoshinori

AU - Kubota, Toshio

AU - Sendo, Toshiaki

AU - Oishi, Ryozo

PY - 2004/5

Y1 - 2004/5

N2 - Background. We previously reported that the apoptotic injury in a porcine renal tubular cell line LLC-PK1 cells induced by radiographic contrast media is attenuated by dibutyl cyclic adenosine monophosphate (cAMP) in a manner dependent on protein kinase A (PKA). The present study was designed to determine whether the elevation of endogenous cAMP with beraprost sodium, a prostacyclin analog, reduces the contrast material-induced renal tubular injury. Methods. The cell injury was induced by the exposure to ioversol for 30 minutes followed by further incubation for 24 hours in the absence of the contrast medium, and assessed by propidium iodide uptake and WST-8 assay. Apoptosis was determined by annexin V stain and DNA electrophoresis. Caspase activity was assessed by the enzymatic degradation of specific substrate peptides. Bax and bcl-2 mRNA expression were determined by reverse transcription-polymerase chain reaction (RT-PCR). The phosphorylation of cAMP-responsive element binding protein (CREB) was measured by an immunofluorescent method. Results. Beraprost sodium (10 to 1000 nmol/L) attenuated concentration dependently the ioversol-induced decrease in cell viability, in which the protective effect of beraprost sodium was dependent on the elevation of cellular cAMP content. The phosphorylation of CREB was enhanced by beraprost sodium in PKA-dependent manner. In addition, beraprost sodium reversed the ioversol-induced increase in bax mRNA with a concomitant decrease in bcl-2 mRNA and subsequent activation of caspase-3 and -9, thereby resulting in the inhibition of the nuclear damage. Conclusion. Beraprost sodium reversed the contrast media-induced renal tubular cells in culture by activating cAMP/protein kinase A-dependent phosphorylation of CREB and subsequent enhancement of bcl-2 expression.

AB - Background. We previously reported that the apoptotic injury in a porcine renal tubular cell line LLC-PK1 cells induced by radiographic contrast media is attenuated by dibutyl cyclic adenosine monophosphate (cAMP) in a manner dependent on protein kinase A (PKA). The present study was designed to determine whether the elevation of endogenous cAMP with beraprost sodium, a prostacyclin analog, reduces the contrast material-induced renal tubular injury. Methods. The cell injury was induced by the exposure to ioversol for 30 minutes followed by further incubation for 24 hours in the absence of the contrast medium, and assessed by propidium iodide uptake and WST-8 assay. Apoptosis was determined by annexin V stain and DNA electrophoresis. Caspase activity was assessed by the enzymatic degradation of specific substrate peptides. Bax and bcl-2 mRNA expression were determined by reverse transcription-polymerase chain reaction (RT-PCR). The phosphorylation of cAMP-responsive element binding protein (CREB) was measured by an immunofluorescent method. Results. Beraprost sodium (10 to 1000 nmol/L) attenuated concentration dependently the ioversol-induced decrease in cell viability, in which the protective effect of beraprost sodium was dependent on the elevation of cellular cAMP content. The phosphorylation of CREB was enhanced by beraprost sodium in PKA-dependent manner. In addition, beraprost sodium reversed the ioversol-induced increase in bax mRNA with a concomitant decrease in bcl-2 mRNA and subsequent activation of caspase-3 and -9, thereby resulting in the inhibition of the nuclear damage. Conclusion. Beraprost sodium reversed the contrast media-induced renal tubular cells in culture by activating cAMP/protein kinase A-dependent phosphorylation of CREB and subsequent enhancement of bcl-2 expression.

UR - http://www.scopus.com/inward/record.url?scp=2342649473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342649473&partnerID=8YFLogxK

U2 - 10.1111/j.1523-1755.2004.00575.x

DO - 10.1111/j.1523-1755.2004.00575.x

M3 - Article

C2 - 15086904

AN - SCOPUS:2342649473

VL - 65

SP - 1654

EP - 1663

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -